• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Jim Cramer: This Tech Stock Is "Great," Archer Aviation Is 'Too Speculative For Me'

    4/11/24 8:37:56 AM ET
    $ACHR
    $BTU
    $GERN
    $HZO
    Aerospace
    Industrials
    Coal Mining
    Energy
    Get the next $ACHR alert in real time by email

    On CNBC’s "Mad Money Lightning Round," Jim Cramer said "no" to MarineMax Inc (NYSE:HZO). "It's just too risky right here," he noted.

    On March 11, MarineMax announced a new stock repurchase program of up to $100 million.

    Trade Desk Inc (NASDAQ:TTD) is "great," Cramer said.

    On Feb. 15, Trade Desk reported better-than-expected fourth-quarter revenue results.

    The "Mad Money" host recommended selling Peabody Energy Corp (NYSE:BTU), adding, "I’m not a coal guy."

    On Feb. 8, Peabody Energy posted weaker-than-expected fourth-quarter earnings.

    Cramer said Geron Corp (NASDAQ:GERN) is "just ok. I mean, we’ve got so many great biotechs these days." He recommended sticking with the "good ones."

    On March 14, Geron Co announced that the U.S. Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee (ODAC) voted in favor of the clinical benefit/risk profile of imetelstat for the treatment of transfusion-dependent anemia.

    Archer Aviation Inc (NYSE:ACHR) is losing a lot of money, Cramer said, "It’s just too speculative for me."

    On Feb. 26, Archer Aviation reported worse-than-expected fourth-quarter financial results.

    Cramer said he likes Uranium Energy Corp. (NYSE:UEC).

    On March 25, Uranium Energy reported the appointment of Brent Berg as Senior Vice-President, U.S. Operations.

    Price Action:

    • MarineMax shares fell 6.4% to settle at $27.50 on Wednesday.
    • Uranium Energy shares gained 3.4% to close at $7.13.
    • Peabody Energy shares gained 0.3% to close at $23.57 during Wednesday’s session.
    • Shares of Trade Desk fell 0.5% to close at $86.44 on Wednesday.
    • Geron shares rose 0.3% to settle at $3.44 on Wednesday.
    • Archer Aviation shares fell 2.8% to close at $4.16.

    Read Next: How To Earn $500 A Month From Citigroup Stock Ahead Of Q1 Earnings Report

    Image: Shutterstock

    Get the next $ACHR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACHR
    $BTU
    $GERN
    $HZO

    CompanyDatePrice TargetRatingAnalyst
    The Trade Desk Inc.
    $TTD
    1/23/2026Mkt Outperform → Mkt Perform
    Citizens JMP
    The Trade Desk Inc.
    $TTD
    1/14/2026$40.00Neutral
    BNP Paribas Exane
    The Trade Desk Inc.
    $TTD
    1/12/2026$39.00Sell → Neutral
    MoffettNathanson
    MarineMax Inc. (FL)
    $HZO
    12/23/2025$29.00Buy
    Loop Capital
    The Trade Desk Inc.
    $TTD
    12/8/2025$50.00 → $40.00Neutral
    Wedbush
    Archer Aviation Inc.
    $ACHR
    12/1/2025$11.00Neutral
    Goldman
    The Trade Desk Inc.
    $TTD
    11/7/2025$65.00Hold → Buy
    The Benchmark Company
    The Trade Desk Inc.
    $TTD
    10/6/2025$68.00 → $53.00Equal Weight
    Wells Fargo
    More analyst ratings

    $ACHR
    $BTU
    $GERN
    $HZO
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by The Trade Desk Inc.

    SCHEDULE 13G/A - Trade Desk, Inc. (0001671933) (Subject)

    2/9/26 11:43:18 AM ET
    $TTD
    Computer Software: Programming Data Processing
    Technology

    SEC Form SCHEDULE 13G filed by The Trade Desk Inc.

    SCHEDULE 13G - Trade Desk, Inc. (0001671933) (Subject)

    2/9/26 8:09:27 AM ET
    $TTD
    Computer Software: Programming Data Processing
    Technology

    SEC Form SCHEDULE 13G filed by Archer Aviation Inc.

    SCHEDULE 13G - Archer Aviation Inc. (0001824502) (Subject)

    2/9/26 6:17:39 AM ET
    $ACHR
    Aerospace
    Industrials

    $ACHR
    $BTU
    $GERN
    $HZO
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    June 7, 2024 - FDA Roundup: June 7, 2024

    For Immediate Release: June 07, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA announced that it has advised the manufacturers of the licensed and authorized COVID-19 vaccines that the COVID-19 vaccines (2024-2025 Formula) for use in the United States should be monovalent (single strain) JN.1 vaccines to more closely match cu

    6/7/24 3:46:22 PM ET
    $GERN
    $SRAX
    $SNAP
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Advertising
    Consumer Discretionary

    FDA Approval for RYTELO issued to GERON CORP

    Submission status for GERON CORP's drug RYTELO (ORIG-1) with active ingredient IMETELSTAT has changed to 'Approval' on 06/06/2024. Application Category: NDA, Application Number: 217779, Application Classification: Type 1 - New Molecular Entity

    6/7/24 12:36:59 PM ET
    $GERN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACHR
    $BTU
    $GERN
    $HZO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    The Trade Desk downgraded by Citizens JMP

    Citizens JMP downgraded The Trade Desk from Mkt Outperform to Mkt Perform

    1/23/26 8:14:54 AM ET
    $TTD
    Computer Software: Programming Data Processing
    Technology

    BNP Paribas Exane initiated coverage on The Trade Desk with a new price target

    BNP Paribas Exane initiated coverage of The Trade Desk with a rating of Neutral and set a new price target of $40.00

    1/14/26 8:50:12 AM ET
    $TTD
    Computer Software: Programming Data Processing
    Technology

    The Trade Desk upgraded by MoffettNathanson with a new price target

    MoffettNathanson upgraded The Trade Desk from Sell to Neutral and set a new price target of $39.00

    1/12/26 7:48:28 AM ET
    $TTD
    Computer Software: Programming Data Processing
    Technology

    $ACHR
    $BTU
    $GERN
    $HZO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP & COO Yeates Darren Ronald sold $505,669 worth of shares (13,892 units at $36.40), decreasing direct ownership by 11% to 113,440 units (SEC Form 4)

    4 - PEABODY ENERGY CORP (0001064728) (Issuer)

    2/12/26 4:11:28 PM ET
    $BTU
    Coal Mining
    Energy

    SEC Form 4 filed by CHIEF ADMINISTRATIVE OFFICER Perkins Tosha

    4 - Archer Aviation Inc. (0001824502) (Issuer)

    2/11/26 8:08:55 PM ET
    $ACHR
    Aerospace
    Industrials

    SEC Form 4 filed by Chief Legal & Strategy Officer Lentell Eric

    4 - Archer Aviation Inc. (0001824502) (Issuer)

    2/11/26 8:07:58 PM ET
    $ACHR
    Aerospace
    Industrials

    $ACHR
    $BTU
    $GERN
    $HZO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Archer To Report Fourth Quarter and Full Year 2025 Operating Update and Financial Results on March 2, 2026

    Archer Aviation Inc. (NYSE:ACHR) will report its fourth quarter and full year 2025 operating update and financial results after market close on Monday, March 2, 2026. The company will host a live webcast to discuss its results at 2:00 p.m. Pacific Time. The live webcast and replay will be available at investors.archer.com. To listen to the conference call, dial +1 646-844-6383 (domestic) or +1 833-470-1428 (international), and enter the access code 043388. Archer will also utilize Say Technologies' Q&A Platform to allow shareholders to submit and vote on questions by visiting https://app.saytechnologies.com/archer-aviation-2025-q4. About Archer Archer is designing and developing the

    2/12/26 5:30:00 PM ET
    $ACHR
    Aerospace
    Industrials

    Record Defense AI Spending Opens a Procurement Window

    Issued on behalf of VisionWave Holdings, Inc. NEW YORK, Feb. 12, 2026 /PRNewswire/ -- USA News Group News Commentary – The Pentagon just carved out its first-ever standalone budget line for autonomy, requesting $13.4 billion for AI-driven platforms[1] across aerial, ground, and maritime domains. That spending lands as the U.S. Army outsources its entire helicopter pilot training pipeline[2] to a single contractor under a 26-year deal at Fort Rucker, replacing four fragmented contracts with one enterprise training up to 1,500 aviators per year. VisionWave Holdings Inc. (NASDAQ:VWAV), Lockheed Martin (NYSE:LMT), Northrop Grumman (NYSE:NOC), Archer Aviation (NYSE:ACHR), and Woodward (NASDAQ:WWD

    2/12/26 10:28:00 AM ET
    $ACHR
    $LMT
    $NOC
    Aerospace
    Industrials
    Military/Government/Technical
    Industrial Machinery/Components

    Geron Plans to Announce Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026

    FOSTER CITY, Calif., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (NASDAQ:GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced that it will release its fourth quarter and full year 2025 financial results and business highlights before the market opens on Wednesday, February 25, 2026 via press release, which will be available on the Investors and Media section of the Company's website. Geron will host a conference call and webcast at 8:00 a.m. Eastern Time. A live and archived audio webcast of the conference call will be available from the Investors and Media section of the Company's website at www.geron.c

    2/11/26 7:27:26 AM ET
    $GERN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACHR
    $BTU
    $GERN
    $HZO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Lawlis V Bryan bought $15,667 worth of shares (13,300 units at $1.18) (SEC Form 4)

    4 - GERON CORP (0000886744) (Issuer)

    5/13/25 4:20:43 PM ET
    $GERN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Biumi Bonnie bought $23,370 worth of shares (1,000 units at $23.37), increasing direct ownership by 100% to 2,000 units (SEC Form 4)

    4 - MARINEMAX INC (0001057060) (Issuer)

    3/12/25 5:00:39 PM ET
    $HZO
    Auto & Home Supply Stores
    Consumer Discretionary

    EVP, Chief Legal Officer Samuels Scott Alan bought $24,150 worth of shares (15,000 units at $1.61), increasing direct ownership by 128% to 26,682 units (SEC Form 4)

    4 - GERON CORP (0000886744) (Issuer)

    3/3/25 6:01:08 AM ET
    $GERN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACHR
    $BTU
    $GERN
    $HZO
    Financials

    Live finance-specific insights

    View All

    Archer To Report Fourth Quarter and Full Year 2025 Operating Update and Financial Results on March 2, 2026

    Archer Aviation Inc. (NYSE:ACHR) will report its fourth quarter and full year 2025 operating update and financial results after market close on Monday, March 2, 2026. The company will host a live webcast to discuss its results at 2:00 p.m. Pacific Time. The live webcast and replay will be available at investors.archer.com. To listen to the conference call, dial +1 646-844-6383 (domestic) or +1 833-470-1428 (international), and enter the access code 043388. Archer will also utilize Say Technologies' Q&A Platform to allow shareholders to submit and vote on questions by visiting https://app.saytechnologies.com/archer-aviation-2025-q4. About Archer Archer is designing and developing the

    2/12/26 5:30:00 PM ET
    $ACHR
    Aerospace
    Industrials

    Geron Plans to Announce Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026

    FOSTER CITY, Calif., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (NASDAQ:GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced that it will release its fourth quarter and full year 2025 financial results and business highlights before the market opens on Wednesday, February 25, 2026 via press release, which will be available on the Investors and Media section of the Company's website. Geron will host a conference call and webcast at 8:00 a.m. Eastern Time. A live and archived audio webcast of the conference call will be available from the Investors and Media section of the Company's website at www.geron.c

    2/11/26 7:27:26 AM ET
    $GERN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Peabody Reports Results for the Quarter and Year Ended December 31, 2025

    Key Operational and Financial Metrics Meet or Exceed 2025 Full-Year Guidance Centurion Longwall Mining Ahead of Schedule U.S. Policy and Market Tailwinds Supportive of Increasing Coal Use ST. LOUIS, Feb. 5, 2026 /PRNewswire/ -- Peabody (NYSE:BTU) today reported fourth quarter net income attributable to common stockholders of $10.4 million, or $0.09 per diluted share, compared to $30.6 million, or $0.25 per diluted share, in the prior year quarter. Peabody had Adjusted EBITDA1 of $118.1 million in the fourth quarter of 2025, compared to $176.7 million in the fourth quarter of 2024. Full-year 2025 revenue totaled $3,861.5 million compared to $4,236.7 million in the prior year in the face of s

    2/5/26 7:46:00 AM ET
    $BTU
    Coal Mining
    Energy

    $ACHR
    $BTU
    $GERN
    $HZO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Archer Aviation Inc.

    SC 13D/A - Archer Aviation Inc. (0001824502) (Subject)

    11/18/24 9:40:14 PM ET
    $ACHR
    Aerospace
    Industrials

    Amendment: SEC Form SC 13G/A filed by Geron Corporation

    SC 13G/A - GERON CORP (0000886744) (Subject)

    11/14/24 5:46:12 PM ET
    $GERN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by The Trade Desk Inc.

    SC 13G/A - Trade Desk, Inc. (0001671933) (Subject)

    11/14/24 4:42:28 PM ET
    $TTD
    Computer Software: Programming Data Processing
    Technology

    $ACHR
    $BTU
    $GERN
    $HZO
    Leadership Updates

    Live Leadership Updates

    View All

    Donerail Issues Open Letter to MarineMax Shareholders

    Calls Out Board Entrenchment, Nepotism, and Obstruction of Shareholder Engagement Urges Shareholders to Vote AGAINST CEO Brett McGill as a Director at Company's Upcoming Annual Meeting Reaffirms $35.00 per Share All-Cash Proposal as a Path to Providing Immediate Shareholder Value at Significant Premium LOS ANGELES, Feb. 09, 2026 (GLOBE NEWSWIRE) -- The Donerail Group ("Donerail"), one of the largest shareholders of MarineMax, Inc. (NYSE:HZO) ("MarineMax" or the "Company"), beneficially owning over 4% of MarineMax's outstanding shares, today issued an open letter to the Company's shareholders further discussing its $35.00 all-cash offer to acquire the Company, its recent engagement with

    2/9/26 9:15:00 AM ET
    $HZO
    Auto & Home Supply Stores
    Consumer Discretionary

    Blood Cancer Therapeutics Reach Critical Commercial and Clinical Inflection Points

    Issued on behalf of GT Biopharma, Inc. USA News Group News Commentary VANCOUVER, BC, Dec. 4, 2025 /PRNewswire/ -- Triple-therapy immunotherapy approaches are demonstrating complete leukemia elimination in preclinical models by reprogramming how cancer cells die to trigger powerful immune responses[1], while breakthrough natural killer cell research is revealing new pathways to supercharge the body's innate tumor-fighting capabilities[2]. These developments position GT Biopharma, Inc. (NASDAQ:GTBP), Geron Corporation (NASDAQ:GERN), Kura Oncology, Inc. (NASDAQ:KURA), SELLAS Life Sciences Group, Inc. (NASDAQ:SLS), and TScan Therapeutics, Inc. (NASDAQ:TCRX). The FDA's November approval of the f

    12/4/25 12:20:00 PM ET
    $GERN
    $GTBP
    $KURA
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Biological Products (No Diagnostic Substances)

    Archer Named Exclusive Air Taxi Partner For The Los Angeles Sports & Entertainment Commission, Will Serve As Official Los Angeles World Cup 2026 Host City Supporter And Official Partner For The Super Bowl LXI Host Committee

    LOS ANGELES, Oct. 22, 2025 /PRNewswire/ -- The Los Angeles Sports & Entertainment Commission (LASEC) today announced Archer (NYSE:ACHR) as its exclusive Air Taxi Partner. As part of this designation, Archer will serve as an Official Los Angeles World Cup 2026 Host City Supporter and an Official Super Bowl LXI Host Committee Partner. This partnership actively expands Archer's presence in Los Angeles by allowing the company to leverage upcoming global events to build excitement for the arrival of air taxis to the region. In conjunction with LASEC, Archer plans to engage with com

    10/22/25 8:30:00 AM ET
    $ACHR
    Aerospace
    Industrials